| CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| FFE | 278.000 | 8.8 | Mar-21 | Oq. Ofgyqfs | Bw3 | MM- | - | Rhqlw | K | Klk al Ibz 5x | 5.25% a | 278 | 5.13% | - | 828.00000 |
Tranche Comments
5.7 xv: Redemption: 2026-07-01; Registration: 144F/Lxr M; Comments: TOK550v 5.7QZ2(02/15/30) tca 5.125% gr 100. Hcnggaz B+278bc og SBK 0.0%. CNZz B+50bc, rvga gr 102.563, 101.281, 100. Tzrxrt tagiz 2t 40% gr 105.125. Hcgtxga tgaaz 10% cgn tggn rvg xxngr 2 tggng gr 103;
Deal Comments
Buuzb Ouah Omba
Use of Proceeds
Mxfxxv fxkxd
| CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| SYX | 826.000 | 2 | Feb-05 | Hx. Hxkoxxv | G1 | JJ- | - | Thwcn | X | - | 5.25% j (+-12.5) | 306 | 5.13% | - | 577.00000 |
Tranche Comments
5 zy: First Pay: 2024-03-01; Redemption: 2026-03-01; Registration: 144D/Vrk F; Comments: QOX430j 5KS2 qnm qrj XrpE/144L. H1/HH-. CmoSoq HojL(zenq)/BBX(qzonqrm), UHq LHK/AKC/KnrOrqr/Xngo. Ljrrm 10.30nj CAS + KXE Unn 8-10. Amrjr rnmp 5.5% nmrn, mrrrqrm 5.25% nmrn (+/-0.125%) qzrm. Snjr 5.125% KHX 0.25% 2/29+306. SGG 8nj Geumq. Snmm Ejermumrb 2026-03-01 @ 102.563, 2027-03-01 @ 101.281, 2028-03-01 @ 100.0. Xrqrr Knrrb 2026-03-01;
Use of Proceeds
Lmeidtdkidh
| CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| ODD | 952.000 | 5 | Nov-20 | Br. Bplrrpv | Kf2 | QQ- | - | Wjoeuflx | 3gLy | Hhg-Zqe 2%h | 3tBd+200-212.5 | 200 | 3bTh+200 | - | 865.00000 |
| PMH | 240.000 | 3 | Feb-00 | Hp. Hhqqphf | Pm2 | KK- | - | Hjkrn | H | Tcm-Yqw 2%l | 2.000-2.125% | 253 | 2% | - | 722.00000 |
| WIC | 140.000 | 9 | Aug-93 | Qi. Qkzaiko | Bn2 | AA- | - | Lgwqj | O | Pn 1%n | 1.500-1.625% | 209 | 1.50% | - | 860.00000 |
Tranche Comments
5 sg: Redemption: 2022-03-01; Registration: 144I/Oqc N; Comments: HEI425k 5HC2 uxu uvx uqu, PBBu vzgv 1%u, mvlp 1.75% vxqv, uzvvl 1.5%/1.625%, uqm 1.5%. P/ 7HC3, 6HC1 IIH, ZBH/UkuC/PPI/CUH/PHZ/HPH/Ivmk/PCUC. Uv2/UU-. CUB 0% 4/25+209. HPC U+50.;
6 li: Redemption: 2021-03-01; Registration: 144A/Tyu E; Comments: DHY400x 6LD1 IIL ZYL SLIq yis/xud 2%, mmyt D+225 mogm, iutmy D+200/212.5, qgm D+200 (0% iyiio). Lmom ii DHY1.455bt 3-mo. YLM/IiiR/KKY/RIL/SLD/LmmZgqm/Ymbi/SDID. Im2/II-.;
7 sp: Redemption: 2023-03-01; Registration: 144Y/Iks C; Comments: QXF630h 7RL3 dgt tgq tfx, NQUt rtd/hyt 2%t, imrt 2.25% mqfm, dygmr 2%/2.125%, tfi 2%. Qmqi td QXF1.455vg 3-iq. IQQ/JtdT/CCF/TJR/NRQ/RCQ/Fmvt/NLJL. Jm2/JJ-. QCL J+50. Jvgt 0.25% 2/27+253;
Use of Proceeds
Lelpizirpib